Study of the association of DFNB3 locus with autosomal recessive non-syndromic hearing loss in iranian deaf population using genetic linkage analysis by Reiisi, Somayeh. et al.
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185 -169  72/0  
1843S17D AATTCAAAGGCTAAAAGCA
AAC  GAGAATCACCTGAACCCG  
203 -159  70/0  
953S17D ACTATCCGCCCAATACA  AAGGGCTTGCTTTGAC  131 -119  76/0  
1857S17D TGCCTAAACTGCTTTCAGGT  TGCACAGGCCAATTCCTTAC  187 -177  62/0  
740S17D TACATTTAATGCAGGATGCC  CTCTTTGTGCTTGGCAGGGT  151 -103  71/0  
2196S17D  CCAACATCTAGAATTAATCA
GAATC  ATATTTCAATATTGTAACCA  
163 -139  81/0  
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Abstract 
Background: Hearing loss is a common sensory disorder that typically illustrates genetic heterogeneity 
in human populations. The incidence of congenital hearing loss is estimated at 1 in 500 births of which 
approximately 70% of cases are attributed to genetic factors. Genetic hearing impairment can be 
classified as either syndromic or non-syndromic and among non-syndromic hearing loss autosomal 
recessive (ALNSHL) accounts for approximately 75-80% of cases. This type of hearing loss is extremely 
heterogeneous and includes over 100 loci. For recessive deafness, most frequent genes are GJB2, 
SLC26A4, MYO15A, OTOF, and CDH23 in worldwide. This study aimed to determine the role of 
MYO15A (DFNB3) gene mutations in Iranian deaf population using linkage analysis.  
Methods: To investigate the frequency of DFNB3 gene mutation, linkage analysis was performed in 
30 Iranian families with over three deaf child and negative GJB2. The negative mutations pedigrees 
for these gene mutations were then tested for the linkage to DFNB3 (MYO15A) locus, using short 
tandem repeat (STR) markers. 
Findings: Mutation 35delG was identified in 5 families out of 30 by sequencing the coding region of 
GJB2 gene. One family showed linkage to DFNB3 locus. 
Conclusion: Based on the results of this study, DFNB3 locus is the third cause of deafness after 
DFNB1 (GJB2) and DFNB4 (SLC26A4). 
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